Stock Events

Stock Events

Search...

Galmed Pharmaceuticals (GLMD) Q4 2025 Earnings

26NovConfirmed

Q2 2025

Q2 2025

Q3 2025

Q4 2025

-1.94

-1.4

-0.87

-0.33

Details

Expected EPS

-0.54

Actual EPS

-0.33

Surprise EPS

0.21

Surprise Percent

+38.89%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -0.33 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.